胸部中心静脉梗阻的血管内再通与重建
胸部中心静脉梗阻(TCVO)指胸部中心静脉闭塞性病变导致头颈、胸部及上肢静脉回流至右心房受阻,病因分良性与恶性,梗阻位于腔内、壁内或血管外。诊断评估始于超声或静脉造影(通常为MR或CT静脉造影,也可能为导管导向或传统静脉造影)。血管内治疗已成为快速安全缓解症状的首选方案,包括血栓切除术、溶栓术及钝性或锐性再通,并通过支架或覆膜支架完成重建;再通重建后可能使用抗血小板和抗凝药物以提高通畅率或治疗深静脉血栓。总体技术和临床成功率高,主要不良事件罕见,发生于1%-2%的患者。
要点
- TCVO指胸部中心静脉闭塞致头颈、胸及上肢静脉回流右心房受阻,病因分良恶性,梗阻位于腔内、壁内或血管外。
- 诊断评估始于超声或静脉造影,通常为MR或CT静脉造影,也可能为导管导向或传统静脉造影。
- 血管内治疗是快速安全缓解症状的首选方案,再通技术包括血栓切除术、溶栓及钝性或锐性再通。
核心结论
- 血管内治疗已成为缓解TCVO症状的首选方案,可快速且安全地减轻症状。
研究设计与样本
- 本文为综述,讨论胸部中心静脉梗阻(TCVO)的病因、诊断评估与血管内再通及重建治疗。
诊断标准与关键数值
- 总体技术和临床成功率高,主要不良事件罕见,发生于1%-2%的患者。
临床应用与阅片要点
- 诊断评估疑似TCVO患者始于超声或静脉造影(通常为MR或CT静脉造影,也可能为导管导向或传统静脉造影)。
- 血管内再通技术包括血栓切除术、溶栓术以及钝性或锐性再通。
- 血管内重建可通过放置支架或覆膜支架完成。
- 再通和重建后可能使用抗血小板和抗凝药物,以提高通畅率或治疗深静脉血栓。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Thoracic central vein obstruction (TCVO) refers to occlusive disease of the thoracic central veins leading to compromised venous return from the head, neck, chest, and upper extremities to the right atrium. TCVO has benign and malignant causes and involves intraluminal, intramural, or extravascular obstruction. TCVO is the preferred term to describe the anatomic and/or pathologic process; however, the clinical manifestations (and historically, the anatomic description) are commonly referred to as superior vena cava syndrome. Diagnostic evaluation of patients with suspected TCVO starts with US or venography (ie, typically MR or CT venography but possibly catheter-directed or conventional venography). Treatment of TCVO has evolved, with endovascular therapy emerging as the preferred treatment option to alleviate symptoms rapidly and safely. Endovascular recanalization techniques include thrombectomy, thrombolysis, and blunt or sharp recanalization. Endovascular reconstruction can be performed by means of placement of stents or stent-grafts. Antiplatelet and anticoagulant agents may be used after recanalization and reconstruction to improve patency rates or to treat deep vein thrombosis. Overall, technical and clinical success rates are high and major adverse events are rare, occurring in 1%-2% of patients. ©RSNA, 2025 Supplemental material is available for this article.
引用
- Fitzgerald KM, Newell KR, Shin DS, et al. Thoracic Central Vein Obstruction Endovascular Recanalization and Reconstruction. Radiographics. 2025. PMID: 41066294. doi:10.1148/rg.240178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。